Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations
News provided by
Share this article
Share this article
AUSTIN, Texas, Dec. 10, 2020 /PRNewswire/ L7 Informatics announced that it has partnered with Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP (Enterprise Science Platform) and implement an integrated manufacturing and lab system. Specifically, L7 will provide Cognate BioServices with a unified data and process automation platform covering manufacturing, quality control, clinical operations, and real-time process intelligence products powered by Microsoft PowerBI.
L7|ESP offers an end-to-end solution for the regulatory compliant automation of ATMP manufacturing and quality control operations from original source samples to final Drug Products including the integration of bio-process equipment and quality control instrum